Cellworks
Cellworks is a life sciences technology company specializing in personalized medicine for oncology and immunology through AI-enhanced biosimulation. Their platform predicts patient responses to FDA-approved drugs using a Therapy Response Index (TRI), which helps physicians select effective cancer treatments and assists biopharma companies in improving clinical trial success and drug development efficiency. Founded in 2005 and backed by major investors like UnitedHealth Group and Sequoia Capital, Cellworks combines molecular biology, cellular pathway modeling, and software technology to deliver transparent, cost-effective, and precise cancer care, improving patient outcomes and reducing healthcare costs.
Cellworks
Cellworks is a life sciences technology company specializing in personalized medicine for oncology and immunology through AI-enhanced biosimulation. Their platform predicts patient responses to FDA-approved drugs using a Therapy Response Index (TRI), which helps physicians select effective cancer treatments and assists biopharma companies in improving clinical trial success and drug development efficiency. Founded in 2005 and backed by major investors like UnitedHealth Group and Sequoia Capital, Cellworks combines molecular biology, cellular pathway modeling, and software technology to deliver transparent, cost-effective, and precise cancer care, improving patient outcomes and reducing healthcare costs.